NEWS and OPINIONS

USAMRIID scientists develop novel 3D bioprinted tissue model
by Quentin Johnson - dvidshub.net - FORT DETRICK, Md.– Scientists at the U.S. Army Medical Research Institute of Infectious Diseases have successfully created a novel 3D bioprinted vascular liver tissue model, marking a significant advancement in biomedical research...

ARPA-H data chief departs over disagreement with mRNA vaccine rollback
By Darren Incorvaia - Fierce Biotech - After the Department of Health and Human Services canceled about $500 million in funding for mRNA vaccine development, one senior agency leader has decided to call it quits. Alastair Thomson is resigning as chief data officer at...

Trained human bone marrow mesenchymal stem cells restore tissue immuno-microenvironment in fulminant hepatic failure mice
By BMC - Part of SpringerNature - Trained immunity with human bone marrow mesenchymal stem cells (hBMSC) is a promising approach to liver regeneration. This study aimed to clarify the trained-hBMSC (T-hBMSC) in restoring tissue immuno-microenvironment in fulminant...

Barcelona Biobank Gets Grant To Research Stem Cell Reprogramming in Wild Animals
By Technology Networks - The Barcelona CryoZoo aims to safeguard and study biological material from a wide range of animal species. The Barcelona CryoZoo is a one-of-a-kind project aiming to safeguard and study biological material from a wide range of animal species –...

Japan MHLW approves Biostar’s angel stem cell therapy for autism
By Pharmaceutical Technology News - Biostar Stem Cell Technology Research Institute has received the Japanese Ministry of Health, Labour and Welfare (MHLW) approval for its angel stem cell therapy for autism spectrum disorder (ASD). Biostar is jointly operated by RBIO...

UCLA scientists develop off-the-shelf immunotherapy for ovarian cancer
By Linda Wang - UCLA Newsroom - Ovarian cancer is the leading cause of death among women with gynecological cancers. The current medical playbook — surgery followed by chemotherapy — initially shows promise. Tumors shrink, sometimes disappearing entirely. But in more...

RFK Jr. Cancels $500 Million In Federal Funding For mRNA Vaccine Research
By Siladitya Ray - Forbes - Health and Human Services Secretary Robert F. Kennedy Jr. announced he is cancelling contracts and grants worth nearly $500 million earmarked to develop mRNA vaccines, as the long-time vaccine critic has repeatedly cast doubts about the...
Top FDA Official’s Surprise Departure Means More Uncertainty for Biotech
By Josh Nathan-Kazis - Barron's - Biotech investors seemed to be taking the sudden departure of a top Food and Drug Administration official last month as a good sign for the sector, but increasing turmoil at the FDA could worsen the picture for drugmakers over the...

Uncertainty clouds the San Diego biotech hub, with jobs and capital scarce
By Jonathan Wosen - Stat - But optimism pokes through, as VC returns and local biotech stocks have fared well Ever since Vince Kato was laid off, he has felt like he was just two to three months away from landing a new position. But more than a year later, he’s...

Study using stem cells created from ALS patients identifies potential new target for treatment
by Case Western Reserve University - The Daily - CLEVELAND—Amyotrophic lateral sclerosis (ALS), known as Lou Gehrig’s disease, is an incurable neurological disorder affecting motor neurons—nerve cells in the brain and spinal cord that control voluntary muscle movement...

VA’s first bloodless stem cell transplant leads to Veteran’s cancer remission
By Abby Woodruff - Veterans Affairs - Earlier this year, VA Tennessee Valley Healthcare System (TVHS) performed the first-ever bloodless autologous stem cell transplant in the VA system. Keith Cody, a Marine Corps Veteran, walked out of TVHS in remission and caught a...

Scientists reprogram stem cells to create renewable cancer-fighting T cells
by Denise Heady, University of California, Los Angeles - MedicalXpress - In a first-of-its-kind clinical trial, UCLA scientists have shown it's possible to reprogram a patient's blood-forming stem cells to generate a continuous supply of functional T cells, the immune...